Your browser doesn't support javascript.
loading
Trends in the approval of cancer therapies by the FDA in the twenty-first century.
Scott, Emma C; Baines, Andrea C; Gong, Yutao; Moore, Rodney; Pamuk, Gulsum E; Saber, Haleh; Subedee, Ashim; Thompson, Matthew D; Xiao, Wenming; Pazdur, Richard; Rao, V Ashutosh; Schneider, Julie; Beaver, Julia A.
Afiliação
  • Scott EC; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA. emma.scott@fda.hhs.gov.
  • Baines AC; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Gong Y; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Moore R; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Pamuk GE; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Saber H; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Subedee A; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Thompson MD; National Cancer Institute, Rockville, MD, USA.
  • Xiao W; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Pazdur R; Office of Oncologic Diseases, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Rao VA; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Schneider J; Office of Biotechnology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Beaver JA; Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, MD, USA.
Nat Rev Drug Discov ; 22(8): 625-640, 2023 08.
Article em En | MEDLINE | ID: mdl-37344568
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Nat Rev Drug Discov Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias / Antineoplásicos Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Nat Rev Drug Discov Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos